1998
Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial
Casson P, Santoro N, Elkind-Hirsch K, Carson S, Hornsby P, Abraham G, Buster J. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertility And Sterility 1998, 70: 107-110. PMID: 9660430, DOI: 10.1016/s0015-0282(98)00121-6.Peer-Reviewed Original ResearchConceptsHigh-density lipoproteinInsulin-like growth factorLevels of DHEADHEA therapySerum DHEAImmune indicesFree insulin-like growth factorDual-energy X-ray absorptiometry scanX-ray absorptiometry scansA1 levelsGrowth factorLiver function testsInsulin-sensitizing propertiesRatio of IGFSmall study sizeSix-month trialPostdose levelsPremenopausal rangePostmenopausal womenIGFBP-3Function testsInsulin sensitivityReferral practicesParallel trialMAIN OUTCOME
1996
Ovarian hyperstimulation augments adrenal dehydroepiandrosterone sulfate secretion**Supported in part by the American College of Obstetricians and Gynecologists-Ortho Academic Training Fellowship, of which Dr. Casson is the 1990-1991 recipient ††Presented in part at the Annual Meetings of the Canadian Fertility and Andrology Society, Quebec, Quebec, Canada, September 11 to 14, 1991; and Kananaskis, alberta, Canada, November 25 to 28, 1992
Casson P, Kristiansen S, Umstot E, Carson S, Buster J. Ovarian hyperstimulation augments adrenal dehydroepiandrosterone sulfate secretion**Supported in part by the American College of Obstetricians and Gynecologists-Ortho Academic Training Fellowship, of which Dr. Casson is the 1990-1991 recipient ††Presented in part at the Annual Meetings of the Canadian Fertility and Andrology Society, Quebec, Quebec, Canada, September 11 to 14, 1991; and Kananaskis, alberta, Canada, November 25 to 28, 1992. Fertility And Sterility 1996, 65: 950-953. PMID: 8612855, DOI: 10.1016/s0015-0282(16)58267-3.Peer-Reviewed Original ResearchConceptsOvarian hyperstimulationHyperstimulation cyclesSerum DHEAStandard ACTH testAdrenal androgen secretionSerum DHEAS levelsOvarian hyperstimulation cyclesProspective clinical studyMain outcome measuresPeak of stimulationDHEAS secretionOvulatory infertilityACTH testInfertile womenF secretionAndrogen secretionCanadian FertilityAndrology SocietyDHEAS levelsInfertility clinicNormal womenE2 levelsIntrapatient variabilityClinical studiesOutcome measures